Skip to main content
Kenneth Mukamal, MD, Internal Medicine, Boston, MA

KennethJMukamalMD

Internal Medicine Boston, MA

Associate Professor of Medicine, Beth Israel Deaconess Medical Center

Dr. Mukamal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mukamal's full profile

Already have an account?

  • Office

    Beth Israel Deaconess Med. Ctr
    330 Brookline Avenue
    Boston, MA 02215
    Phone+1 617-667-9600
    Fax+1 617-667-9696

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1994 - 2026
  • CT State Medical License
    CT State Medical License 1993 - 1994
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Multimorbidity and Mental Health‐Related Quality of Life and Risk of Completed Suicide  
    Melissa Y Wei, Kenneth J Mukamal, Journal of the American Geriatrics Society
  • Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction  
    Kenneth J Mukamal, Nancy R Cook, Kathryn M Rexrode, ScienceDirect
  • The Associations of Subclinical Atherosclerotic Cardiovascular Disease with Hip Fracture Risk and Bone Mineral Density in Elderly Adults  
    K J Mukamal, J I Barzilay, J A Robbins, Osteoporosis international

Other

Press Mentions

  • Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD
    Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBDOctober 7th, 2022
  • Many Older Adults Are Not Getting Prescribed the Blood Pressure Treatment They Need
    Many Older Adults Are Not Getting Prescribed the Blood Pressure Treatment They NeedSeptember 20th, 2022
  • Many Older Adults May Not Get the Intensive Blood Pressure Treatment They Need
    Many Older Adults May Not Get the Intensive Blood Pressure Treatment They NeedSeptember 16th, 2022
  • Join now to see all

Grant Support

  • Determinants And Cardiovascular Consequences Of Diabetes In Older AdultsNational Heart, Lung, And Blood Institute2009–2011
  • Endothelial Dysfunction, Oxidative Stress And Risk Of Peripheral Arterial DiseaseNational Heart, Lung, And Blood Institute2009–2010
  • Alcohol And Atherosclerosis Pilot StudyNational Institute On Alcohol Abuse And Alcoholism2008–2009
  • Heavy Drinking &Coronary Disease: Acute/Chronic EffectsNational Institute On Alcohol Abuse And Alcoholism2005–2006
  • TEA And AtherosclerosisNational Center For Research Resources2004–2005
  • Moderate Alcohol Use &Health: Preferences &OutcomesNational Institute On Alcohol Abuse And Alcoholism2000–2002
  • Moderate Alcohol Use And Health--Preferences And OutcomeNational Institute On Alcohol Abuse And Alcoholism1999
  • COST Effectiveness Changes In National Alcohol UseNational Institute On Alcohol Abuse And Alcoholism1998